Jeffrey M. Dayno - Aug 10, 2021 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: Chief Medical Officer
Signature: /s/ Christian Ulrich, Attorney-in-fact
Stock symbol: HRMY
Transactions as of: Aug 10, 2021
Transactions value $: -$218,845
Form type: 4
Date filed: 8/11/2021, 04:30 PM
Previous filing: Jul 23, 2021
Next filing: Aug 30, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRMY	Common Stock	Options Exercise	$81.8K	+9.95K		$8.22^*	9.95K	Aug 10, 2021	Direct
transaction	HRMY	Common Stock	Sale	-$301K	-9.95K	-100%	$30.21	0	Aug 10, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRMY	Stock Option	Options Exercise	$0	-9.95K	-9.62%	$0.00	93.5K	Aug 10, 2021	Common Stock	9.95K	$8.22	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.75. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The stock option is currently vested with respect to 82,777 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 13, 2021.